Transcapillary Plasma Refill in Advanced Chronic Kidney Disease
PRUf
An Investigation of Transcapillary Plasma Refill During Ultrafiltration in Haemodialysis
1 other identifier
interventional
24
1 country
1
Brief Summary
Background: Haemodynamic instability during haemodialysis has long been linked to poor cardiovascular outcomes. It does not always reflect overall hydration but rather plasma volume depletion, with a delay in plasma refill from other body compartments, and vasodilatation, mediated by endothelial factors. Our understanding of these processes remains largely incomplete. Despite our ability to monitor relative blood volume during haemodialysis our knowledge concerning the factors affecting plasma refill remain incomplete. This may be due to variations observed between individuals. Understanding the pattern of fluid shifts variation between the different body compartment and the factors affecting these behaviours in different individuals or at different hydration states could be a vital component of our management of intradialytic haemodynamic instability but also overhydration. Aims and Objectives: The aim of this study is to describe plasma refill rate, during haemodialysis using a non-invasive, continuous, real-time data capture during ultrafiltration. The study will attempt to describe different refilling phenotypes in the study population and seek association with biochemical and haematological parameters linked to variability in refilling rates. Methodology: This study will attempt to describe variations in the plasma refill rate of prevalent dialysis patients during their normal haemodialysis treatment and during a session of 3 hours of haemodialysis preceded by 1 hour of isolated ultrafiltration using the in-built blood volume monitoring module of their haemodialysis machine and the TMON software that collects continuous, real-time data by interfacing with the computer network. To achieve this, a bolus of 100-300ml of intravenous dialysis replacement fluid will be administered at the beginning of each of the 2 studied sessions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 21, 2017
CompletedFirst Posted
Study publicly available on registry
November 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 8, 2019
CompletedAugust 15, 2019
August 1, 2019
2.5 years
August 21, 2017
August 14, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Plasma refilling rate
To assess absolute plasma volume changes during ultrafiltration on haemodialysis
Continuous derivation of the refilling rate during a four hour haemodialysis treatment
Study Arms (2)
Standard ultrafiltration
NO INTERVENTIONstandard ultrafiltration (fluid removal from the body by dialysis at the prescribed volume and rate) during a conventional treatment
High dose ultrafiltration
ACTIVE COMPARATORIntervention= Fixed rate high dose ultrafiltration (fluid removed from the body by dialysis) of 1 litre per hour over 1 hr instaed of standard ultrafiltration rate and volume.
Interventions
Fixed high volume of ultrafiltration over an hour during dialysis
Eligibility Criteria
You may qualify if:
- Prevalent haemodialysis patient at CMFT and satellite units
You may not qualify if:
- Withdrawal of consent.
- Inability to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Manchester University NHS Foundation Trustlead
- University of Manchestercollaborator
- Manchester Metropolitan Universitycollaborator
- University of Birminghamcollaborator
Study Sites (1)
Manchester University NHS Foundation Trust
Manchester, M13 9WL, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Sandip Mitra
Manchester University NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 21, 2017
First Posted
November 21, 2017
Study Start
September 1, 2016
Primary Completion
March 8, 2019
Study Completion
March 8, 2019
Last Updated
August 15, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share